BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21143336)

  • 1. Differential effects of advanced glycation end-products on renal tubular cell inflammation.
    Tang SC; Chan LY; Leung JC; Cheng AS; Lin M; Lan HY; Lai KN
    Nephrology (Carlton); 2011 May; 16(4):417-25. PubMed ID: 21143336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic tubulopathy: an emerging entity.
    Tang SCW; Leung JCK; Lai KN
    Contrib Nephrol; 2011; 170():124-134. PubMed ID: 21659765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells.
    Cheng M; Liu H; Zhang D; Liu Y; Wang C; Liu F; Chen J
    Am J Nephrol; 2015; 41(3):257-66. PubMed ID: 25924590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of tubular epithelial cells in diabetic nephropathy.
    Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
    Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4.
    Kaifu K; Ueda S; Nakamura N; Matsui T; Yamada-Obara N; Ando R; Kaida Y; Nakata M; Matsukuma-Toyonaga M; Higashimoto Y; Fukami K; Suzuki Y; Okuda S; Yamagishi SI
    Microvasc Res; 2018 Nov; 120():90-93. PubMed ID: 30056058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist.
    Tang SC; Leung JC; Chan LY; Tsang AW; Lai KN
    J Am Soc Nephrol; 2006 Jun; 17(6):1633-43. PubMed ID: 16687627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin and glycated albumin activate KIM-1 release in tubular epithelial cells through distinct kinetics and mechanisms.
    Lim AI; Chan LY; Tang SC; Lai KN; Leung JC
    Inflamm Res; 2014 Oct; 63(10):831-9. PubMed ID: 25063374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
    Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
    Morcos M; Schlotterer A; Sayed AA; Kukudov G; Oikomonou D; Ibrahim Y; Pfisterer F; Schneider J; Bozorgmehr F; Rudofsky G; Schwenger V; Kientsch-Engels R; Hamann A; Zeier M; Dugi K; Yard B; Humpert PM; van der Woude F; Nawroth PP; Bierhaus A
    Horm Metab Res; 2008 Nov; 40(11):752-9. PubMed ID: 18711692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis.
    Wu HJ; Yiu WH; Li RX; Wong DW; Leung JC; Chan LY; Zhang Y; Lian Q; Lin M; Tse HF; Lai KN; Tang SC
    PLoS One; 2014; 9(3):e90883. PubMed ID: 24646687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between proximal tubular epithelial cells and infiltrating monocytes/T cells in the proteinuric state.
    Lai KN; Leung JC; Chan LY; Guo H; Tang SC
    Kidney Int; 2007 Mar; 71(6):526-38. PubMed ID: 17245394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes.
    Rasheed Z; Akhtar N; Haqqi TM
    Rheumatology (Oxford); 2011 May; 50(5):838-51. PubMed ID: 21172926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.
    Nagai R; Matsumoto K; Ling X; Suzuki H; Araki T; Horiuchi S
    Diabetes; 2000 Oct; 49(10):1714-23. PubMed ID: 11016456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.
    Liu J; Huang K; Cai GY; Chen XM; Yang JR; Lin LR; Yang J; Huo BG; Zhan J; He YN
    Cell Signal; 2014 Jan; 26(1):110-21. PubMed ID: 24113348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.
    Chung AC; Zhang H; Kong YZ; Tan JJ; Huang XR; Kopp JB; Lan HY
    J Am Soc Nephrol; 2010 Feb; 21(2):249-60. PubMed ID: 19959709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells.
    Yamagishi S; Inagaki Y; Okamoto T; Amano S; Koga K; Takeuchi M
    Kidney Int; 2003 Feb; 63(2):464-73. PubMed ID: 12631112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
    Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
    Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor.
    An XF; Zhou L; Jiang PJ; Yan M; Huang YJ; Zhang SN; Niu YF; Ten SC; Yu JY
    Mol Cell Biochem; 2011 Aug; 354(1-2):47-55. PubMed ID: 21461610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor.
    Westwood ME; McLellan AC; Thornalley PJ
    J Biol Chem; 1994 Dec; 269(51):32293-8. PubMed ID: 7798229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.